Gastrointestinal Cancer News

Fox Chase Cancer Center and Temple Health announced several faculty appointments.

A community-based oncology consortium effectively gathered nearly 2,000 unique genomic data sets from Black patients with cancer residing in Black Belt states, according to study results.

Although efforts have been made to increase sharing of individual participant data from clinical trials, data from many oncology clinical trials that support FDA approval of anticancer therapies remain unavailable to researchers.

Artificial intelligence-assisted colonoscopy improved overall adenoma detection rate compared with conventional colonoscopy, according to research published in Clinical Gastroenterology and Hepatology.

During the early months of the COVID-19 pandemic, the number of cancer screenings in the U.S. dropped sharply as states imposed stay-at-home orders and health care providers sought to reduce exposure to the virus and redeployed personnel.

President Joe Biden has chosen surgical oncologist Monica M. Bertagnolli, MD, FACS, FASCO, to serve as director of the National Cancer Institute, according to published reports.

In this video, Smitha S. Krishnamurthi, MD, discussed the results of the STRATEGIC-1 trial, which she said validates a common initial treatment strategy for patients with RAS and BRAF wild-type metastatic colorectal cancer.

The Association of Coloproctology of Great Britain and Ireland and the British Society of Gastroenterology have published a joint guideline for the strategic use of fecal immunochemical testing in people with suspected colorectal cancer.

LONDON — Longitudinal serum alanine aminotransferase trajectories remained stable over time among a subset of patients with nonalcoholic fatty liver disease, according to research presented at the International Liver Congress.

Researchers have discovered geographic patterns of mortality rates among patients with young-onset colorectal cancer in the United States, according to findings published in Gastroenterology.